Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.

Vanderbilt's Melinda Buntin, PhD, has been offered a Bloomberg Distinguished Professorship at Johns Hopkins University.

Vanderbilt's Stacie Dusetzina, PhD, and several colleagues were able to reflect recently on the South Lawn of the White House about how their contributions through research and data informed the provisions in the Inflation Reduction Act that will save older Americans on Medicare tens of thousands of dollars in out-of-pocket costs each year.

A panel of experts on opioid use disorder (OUD) recently discussed the importance of building recovery ecosystems or networks of resources to respond to the opioid epidemic.

Rahul Gupta, MD, MPH, MBA, director of National Drug Control Policy visited Vanderbilt last week to learn about the Medical Center’s efforts related to child-maternal addiction care, the Firefly program and Team Hope.

Vanderbilt research finds that hospitals' 30-day readmission rates were lower if they had a larger supply of primary care physicians, nursing homes or palliative care services nearby.

Vanderbilt researchers found that both gender dysphoria diagnoses and use of gender therapies have increased substantially between 2013 and 2019.